🇺🇸 FDA
Patent

US 8653027

Method of treatment of type-1 diabetes with humanin analogues

granted A61KA61K31/7088A61K38/1709

Quick answer

US patent 8653027 (Method of treatment of type-1 diabetes with humanin analogues) held by The Regents of the University of California expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/7088, A61K38/1709, A61P, A61P3/10